Announced
Completed
Financials
Tags
Private Equity
United States
Domestic
biopharma
Majority
Acquisition
Privatisation
Biotechnology
Friendly
Public
Completed
Single Bidder
Synopsis
Gurnet Point Capital, a private equity and venture capital firm, and Patient Square Capital, a health care investment firm, completed the acquisition of Radius Health, a biopharmaceutical company, for $890m. “We are delighted to be acquiring Radius and providing additional resources to the Company during this critical time. We fully believe in the value of the Company’s portfolio and are looking forward to working closely with the Company to deliver a positive impact for patients,” Travis Wilson, Gurnet Point Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.